Antares Pharma
ATRS
#5981
Rank
โ‚ฌ0.83 B
Marketcap
4,87ย โ‚ฌ
Share price
0.00%
Change (1 day)
21.56%
Change (1 year)

Revenue for Antares Pharma (ATRS)

Revenue in 2021: โ‚ฌ0.16 Billion

According to Antares Pharma's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.16 Billion. In 2021 the company made a revenue of โ‚ฌ0.16 Billion an increase over the revenue in the year 2020 that were of โ‚ฌ0.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Antares Pharma from 1996 to 2021

Annual revenue

Year Revenue Change
2021โ‚ฌ0.16 B22.98%
2020โ‚ฌ0.13 B20.78%
2019โ‚ฌ0.10 B94.9%
2018โ‚ฌ55.33 M16.58%
2017โ‚ฌ47.46 M4.39%
2016โ‚ฌ45.46 M14.38%
2015โ‚ฌ39.75 M72.28%
2014โ‚ฌ23.07 M28.53%
2013โ‚ฌ17.95 M-8.67%
2012โ‚ฌ19.65 M37.17%
2011โ‚ฌ14.33 M28.39%
2010โ‚ฌ11.16 M54.24%
2009โ‚ฌ7.23 M46.82%
2008โ‚ฌ4.92 M-27.95%
2007โ‚ฌ6.84 M84.07%
2006โ‚ฌ3.71 M91.86%
2005โ‚ฌ1.93 M-18.98%
2004โ‚ฌ2.39 M-27.49%
2003โ‚ฌ3.29 M-5.23%
2002โ‚ฌ3.47 M14.21%
2001โ‚ฌ3.04 M75.52%
2000โ‚ฌ1.73 M-42.75%
1999โ‚ฌ3.03 M26.57%
1998โ‚ฌ2.39 M-25.99%
1997โ‚ฌ3.23 M0.68%
1996โ‚ฌ3.21 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ80.23 B 49,985.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ54.66 B 34,026.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ51.73 B 32,196.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
โ‚ฌ19.01 B 11,770.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ0.71 B 349.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Retractable Technologies
RVP
โ‚ฌ33 M-79.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ15.02 B 9,280.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
West Pharmaceutical Services
WST
โ‚ฌ2.62 B 1,540.32%๐Ÿ‡บ๐Ÿ‡ธ USA